ALDACTAZIDE Side Effects

6793803-X | Blood Pressure Increased, Fluid Retention, Weight Increased
on May 08, 2009 Female patient from UNITED STATES , weighting 130.1 lb, was diagnosed with hypothyroidism and was treated with Aldactazide (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, fluid retention, weight increased. Aldactazide dosage: 50 Mg, 2x/day. During the same period patient was treated with SYNTHROID (Unk) (View Synthroid Review and Synthroid Label ).

6788449-3 | Hyperthyroidism, Hypothyroidism
Patient was taking Aldactazide (View Usage). Patient had the following side effects: hyperthyroidism, hypothyroidism on Mar 04, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 160.0 lb, was diagnosed with fluid retention, hypothyroidism and. Aldactazide dosage: 25/25 Mg. During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ).

5304964-3 | Face Oedema, Hypoaesthesia, Lip Swelling
Adverse event was reported on Apr 12, 2007 by a Female patient taking Aldactazide (View Usage) (Dosage: Daily Dose:25mg) was diagnosed with oedema and. Location: JAPAN , 58 years of age, After Aldactazide was administered, patient had the following side effects: face oedema, hypoaesthesia, lip swelling. During the same period patient was treated with ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ), CALTAN (View Caltan Review and Caltan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), MYSLEE (View Myslee Review and Myslee Label ), ZANTAC (View Zantac Review and Zantac Label ), BLOPRESS (View Blopress Review and Blopress Label ), LUVOX (View Luvox Review and Luvox Label ).

5296886-1 | Face Oedema, Hypoaesthesia, Lip Swelling
on Apr 05, 2007 Female patient from JAPAN , 58 years of age, was treated with Aldactazide (View Usage). Patient experienced the following unwanted or unexpected effects: face oedema, hypoaesthesia, lip swelling. Aldactazide dosage: Daily Dose:25mg. During the same period patient was treated with ZYLORIC ^FRESENIUS^ (View Zyloric ^fresenius^ Review and Zyloric ^fresenius^ Label ), CALTAN (View Caltan Review and Caltan Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LENDORMIN (View Lendormin Review and Lendormin Label ), MYSLEE (View Myslee Review and Myslee Label ), ZANTAC (View Zantac Review and Zantac Label ), BLOPRESS (View Blopress Review and Blopress Label ), LUVOX (View Luvox Review and Luvox Label ).


5285312-4 | Asthenia, Malaise, Muscle Spasms, Renal Failure Acute
on Mar 26, 2007 Female patient from SPAIN , 85 years of age, was diagnosed with cardiac failure, ischaemic cardiomyopathy and was treated with Aldactazide (View Usage). Patient had the following side effects: asthenia, malaise, muscle spasms, renal failure acute. Aldactazide dosage: . During the same period patient was treated with SEGURIL (View Seguril Review and Seguril Label ), ACOVIL (View Acovil Review and Acovil Label ), CORDIPLAST (Daily Dose:10mg) (View Cordiplast Review and Cordiplast Label ), TROMALYT (Daily Dose:150mg) (View Tromalyt Review and Tromalyt Label ), LOSEC (Daily Dose:20mg) (View Losec Review and Losec Label ). Patient was hospitalized.

5192428-X | Blood Glucose Decreased, Blood Pressure Increased, Diabetes Mellitus, Face Oedema, Feeling Abnormal, Head Injury, Hypotension, Infection, Localised Oedema
Patient was taking Aldactazide (View Usage). After Aldactazide was administered, patient had the following side effects: blood glucose decreased, blood pressure increased, diabetes mellitus, face oedema, feeling abnormal, head injury, hypotension, infection (What is infection?), localised oedema on Dec 09, 2006 from UNITED STATES Additional patient health information: Female patient , 63 years of age, weighting 185.0 lb, was diagnosed with hypertension and. Aldactazide dosage: . During the same period patient was treated with TAURINE (View Taurine Review and Taurine Label ), PENICILLINE (BENZYLPENICILLIN SODIUM) (View Penicilline (benzylpenicillin Sodium) Review and Penicilline (benzylpenicillin Sodium) Label ).

5155425-6 | Blood Glucose Decreased, Blood Pressure Increased, Diabetes Mellitus, Feeling Abnormal, Fluid Retention, Head Injury, Hypotension, Ill-defined Disorder, Infection
Adverse event was reported on Nov 01, 2006 by a Female patient taking Aldactazide (View Usage) (Dosage: ) . Location: UNITED STATES , 63 years of age, weighting 185.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose decreased, blood pressure increased, diabetes mellitus, feeling abnormal, fluid retention, head injury, hypotension, ill-defined disorder, infection (What is infection?). During the same period patient was treated with TAURINE (TAURINE) (View Taurine (taurine) Review and Taurine (taurine) Label ), PENICILLINE (BENZYLPENICILLIN SODIUM) (View Penicilline (benzylpenicillin Sodium) Review and Penicilline (benzylpenicillin Sodium) Label ).

5142567-4 | Blood Pressure Increased, Heart Rate Irregular, Palpitations, Sensory Disturbance, Tachycardia
on Oct 16, 2006 Female patient from UNITED STATES , 63 years of age, was treated with Aldactazide (View Usage). Patient had the following side effects: blood pressure increased, heart rate irregular, palpitations, sensory disturbance, tachycardia. Aldactazide dosage: .

4957740-5 | Blister, Hypokalaemia, Hyponatraemia, Hypotension, Oedema Peripheral
on Mar 13, 2006 Female patient from UNITED STATES , 67 years of age, was diagnosed with ill-defined disorder and was treated with Aldactazide (View Usage). After Aldactazide was administered, patient had the following side effects: blister, hypokalaemia, hyponatraemia, hypotension, oedema peripheral. Aldactazide dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), GLUCOVANCE (View Glucovance Review and Glucovance Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ZOLOFT (View Zoloft Review and Zoloft Label ), PREVACID (LANSPORAZOLE) (View Prevacid (lansporazole) Review and Prevacid (lansporazole) Label ). Patient was hospitalized.

4674034-6 | Adenocarcinoma Pancreas, Confusional State, Haemoglobin Increased, Hypochloraemia, Hypoglycaemia, Hyponatraemia, Pain
Patient was taking Aldactazide (View Usage). Patient experienced the following unwanted or unexpected effects: adenocarcinoma pancreas, confusional state, haemoglobin increased, hypochloraemia, hypoglycaemia, hyponatraemia, pain (What is pain?) on May 13, 2005 from Additional patient health information: Female patient , 70 years of age, weighting 165.3 lb, was diagnosed with hypertension and. Aldactazide dosage: 1 Df (od), Oral. During the same period patient was treated with LITHIUM CARBOANTE (LITHIUM CARBONATE) (View Lithium Carboante (lithium Carbonate) Review and Lithium Carboante (lithium Carbonate) Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIQUIDONE (GLIQUIDONE) (View Gliquidone (gliquidone) Review and Gliquidone (gliquidone) Label ), INSULIN (View Insulin Review and Insulin Label ), PARACETAMOL (PARACETAMOL) (View Paracetamol (paracetamol) Review and Paracetamol (paracetamol) Label ), NSAID'S (NSAID'S) (View Nsaid's (nsaid's) Review and Nsaid's (nsaid's) Label ). Patient was hospitalized.

4596420-5 | Adenocarcinoma Pancreas, Back Pain, Blood Pressure Increased, Confusional State, Haemoglobin Increased, Hypochloraemia, Hypoglycaemia, Hyponatraemia, Malignant Neoplasm Progression
Adverse event was reported on Feb 15, 2005 by a Female patient taking Aldactazide (View Usage) (Dosage: 1 Df (od), Oral) was diagnosed with hypertension and. Location: , 70 years of age, weighting 165.3 lb, Patient had the following side effects: adenocarcinoma pancreas, back pain (What is back pain?), blood pressure increased, confusional state, haemoglobin increased, hypochloraemia, hypoglycaemia, hyponatraemia, malignant neoplasm progression. During the same period patient was treated with LITHIUM CARBONATE (View Lithium Carbonate Review and Lithium Carbonate Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), GLIQUIDONE (GLIQUIDONE) (View Gliquidone (gliquidone) Review and Gliquidone (gliquidone) Label ), INSULIN (View Insulin Review and Insulin Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), NSAID'S (NSAID'S) (View Nsaid's (nsaid's) Review and Nsaid's (nsaid's) Label ). Patient was hospitalized.